Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.
Fulminant Epstein-Barr virus (EBV)-driven clonal T-cell lymphoproliferative disorder (T-LPD) is rare and most patients are of Asian origin. The disease usually develops shortly after primary acute EBV infection and the mechanism remains poorly understood. Here we report such a rare case in a 28-year-old Caucasian female with systemic lupus erythematosus (SLE). Immunophenotypic and molecular studies revealed that the proliferating lymphoid cells displayed a CD8(+) T-cell phenotype with clonal rearrangement of the T-cell receptor gamma gene. Epstein-Barr virus-encoded RNA was also observed in the clonal lymphoid cells by in situ hybridization. The patient subsequently developed fatal virus-associated hemophagocytic syndrome one month after the primary acute EBV infection. The case represents the first report of fulminant EBV-driven CD8(+) T-LPD occurring in an immunocompromised Caucasian SLE patient. This study, along with studies of similar Asian cases reported in the literature, suggests that dysregulated immunity due to either acquired or genetically determined susceptibility may result in an abnormal response to primary EBV infection and contribute to the pathogenesis of EBV-mediated fatal T-LPD.
Young
Ken H
KH
Departments of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. khyoung@wisc.edu
Zhang
Dahua
D
Malik
Jeffery T
JT
Williams
Eliot C
EC
J Immunol. 1992 Aug 1;149(3):768-74
1386093
Blood. 2001 Sep 15;98(6):1882-8
11535525
N Engl J Med. 1995 Jan 5;332(1):12-8
7990860
J Immunol. 2005 Jun 1;174(11):6599-607
15905498
Am J Pathol. 1992 Jun;140(6):1315-25
1318639
Oncogene. 2005 Sep 5;24(39):6047-57
16155611
Am J Hematol. 1996 Oct;53(2):111-5
8892735
Gastroenterology. 1987 Dec;93(6):1210-7
3678738
Jpn J Cancer Res. 1989 Feb;80(2):99-101
2542204
Am J Clin Pathol. 2006 Jun;125(6):884-94
16690488
Am J Clin Pathol. 1992 Sep;98(3):324-33
1326893
Br J Haematol. 2001 Feb;112(2):377-80
11167833
Herpes. 2006 May;13(1):12-6
16732997
Blood. 2000 Jul 15;96(2):443-51
10887104
Clin Immunol. 2006 Apr;119(1):79-86
16386957
Arch Pathol Lab Med. 1987 Jun;111(6):530-5
3579509
J Immunol. 1991 Feb 1;146(3):865-9
1703182
Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S46-55
9894469
Eur J Pediatr. 1994 Oct;153(10):734-8
7813531
Hematology Am Soc Hematol Educ Program. 2006;:317-22
17124078
Lancet. 1991 Feb 9;337(8737):320-2
1671232
Am J Clin Pathol. 1992 Feb;97(2):189-94
1372145
Blood. 1998 Mar 15;91(6):2085-91
9490694
Int J Surg Pathol. 2006 Jan;14(1):43-8
16501834
Ann Intern Med. 1993 Jan 1;118(1):45-58
8380053
J Clin Invest. 1993 Sep;92(3):1444-50
8397226
J Gen Virol. 1988 May;69 ( Pt 5):1051-65
2836550
Arthritis Res Ther. 2004;6(4):R295-302
15225364
Hum Pathol. 1993 Oct;24(10):1135-9
8406423
J Virol. 1988 Apr;62(4):1442-7
2831405
Autoimmunity. 2005 Nov;38(7):473-85
16373252
N Engl J Med. 1988 Mar 24;318(12):733-41
2831453
Am J Pathol. 1991 Sep;139(3):469-74
1653517
Ann Rheum Dis. 2005 Oct;64(10):1507-9
16162903
Cancer Genet Cytogenet. 1993 Aug;69(1):25-30
8397064
Curr Opin Hematol. 2000 Jan;7(1):59-63
10608506
Cancer. 1990 Dec 15;66(12):2557-62
2174302
N Engl J Med. 1989 Mar 16;320(11):689-95
2537928
Hum Pathol. 1994 Jun;25(6):602-5
8013952
Pathol Int. 1998 Dec;48(12):934-43
9952337
Blood. 1997 Nov 15;90(10):4099-105
9354680
J Exp Med. 1991 Apr 1;173(4):971-80
1706754
Autoimmunity. 2006 Feb;39(1):63-70
16455583
Science. 1993 Apr 2;260(5104):98-100
7682013
N Engl J Med. 1992 Jul 2;327(1):58
1317943
Nature. 1988 Jun 2;333(6172):455-7
2836734
N Engl J Med. 1989 Feb 23;320(8):502-6
2536894
Expert Rev Anti Infect Ther. 2006 Dec;4(6):1039-49
17181419
Med Oncol. 2003;20(4):409-12
14716040
Cancer. 1979 Sep;44(3):993-1002
225008
Int J Hematol. 2005 Aug;82(2):169-70
16146852
Blood. 1999 Jul 1;94(1):244-50
10381519
Am J Surg Pathol. 1994 Jun;18(6):623-31
8179077
Int J Hematol. 2001 Dec;74(4):451-4
11794703
Lab Invest. 1992 Jul;67(1):5-23
1320711
Nat Genet. 1998 Oct;20(2):129-35
9771704
Leukemia. 1992 Sep;6(9):952-6
1325583
N Engl J Med. 1995 Jan 5;332(1):19-25
7990861
N Engl J Med. 2000 Aug 17;343(7):481-92
10944566
Hematology Am Soc Hematol Educ Program. 2005;:260-6
16304390
Arthritis Rheum. 2005 May;52(5):1481-90
15880596
Am J Clin Pathol. 1995 Feb;103(2):189-94
7856561
Int J Cancer. 1990 Dec 15;46(6):976-84
2174416
Clin Immunol Immunopathol. 1990 Oct;57(1):32-44
2168301
Immunity. 2001 Nov;15(5):775-85
11728339
Curr Dir Autoimmun. 2004;7:33-48
14719374
J Gen Virol. 1990 Feb;71 ( Pt 2):379-86
2155291